Downregulated gene products include putative tumor suppressor genes (SCUBE2), factors previously reported as lost in aggressive bladder cancer (FOXA1, GATA3, UPK3A), and metabolizing enzymes with polymorphisms affecting cancer risk (UGT1A10, UGT1A7). This evidence concerns the gene UGT1A7 and cancer.